We are live on ! Find out more
CGL

Clarius Group LLC Portfolio holdings

AUM $1.75B
1-Year Est. Return 19.04%
This Fund
S&P 500
This Quarter Est. Return
+13.11%
1 Year Est. Return
+19.04%
3 Year Est. Return
+92.07%
5 Year Est. Return
+98.79%
10 Year Est. Return
+415.93%
AUM
$1.45B
AUM Growth
+$242M
Cap. Flow
+$106M
Cap. Flow %
7.32%
Top 10 Hldgs %
57.89%
Holding
503
New
26
Increased
66
Reduced
352
Closed
19
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XEL icon
501
Xcel Energy
XEL
$48.8B
-5,542
Closed -$343K
CBAY
502
DELISTED
Cymabay Therapeutics
CBAY
-8,938
Closed -$211K
KRTX
503
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
-69,248
Closed -$21.9M

Similar funds

Clarius Group LLC's Q1 2024 Portfolio in Review

As of Q1 2024, Clarius Group LLC held 503 positions worth $1.45B, up 20% from $1.21B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Clarius Group LLC deployed $106M of net new capital in Q1 2024, opening 26 new positions and adding to 66 existing holdings. Its largest new stake was Eversource Energy: 5,003 shares worth $299K.

By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 11% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Invesco Russell 1000 Dynamic Multifactor ETF, an estimated $19.7M trimmed.

  • Clarius Group LLC's largest Q1 2024 buy was Eversource Energy: 5,003 shares worth $299K.
  • Clarius Group LLC added most to PACCAR in Q1 2024, an estimated $140M increase.
  • Clarius Group LLC's biggest Q1 2024 reduction was Invesco Russell 1000 Dynamic Multifactor ETF, cutting an estimated $19.7M.
  • Clarius Group LLC fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $21.9M.
  • Clarius Group LLC's ten largest holdings make up 58% of its $1.45B portfolio in Q1 2024.
  • Clarius Group LLC opened 26 new positions and closed 19 in Q1 2024.
  • Clarius Group LLC's portfolio value rose 20% quarter-over-quarter to $1.45B.

Based on Clarius Group LLC's 13F filing for Q1 2024, filed 17 Apr 2024.